Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Richard, Chubet"'
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 4 (2022)
While there are several SARS-CoV-2 vaccines currently available, additional options must be provided that are safe, effective, and affordable for the entire global population. We have developed a novel immune activating platform technology that will
Externí odkaz:
https://doaj.org/article/a81593c2cee547ceb8098406793dc9fc
Autor:
Clifton, McPherson, Richard, Chubet, Kathy, Holtz, Yoshikazu, Honda-Okubo, Dale, Barnard, Manon, Cox, Nikolai, Petrovsky
Publikováno v:
Vaccine Design
Given periodic outbreaks of fatal human infections caused by coronaviruses, development of an optimal coronavirus vaccine platform capable of rapid production is an ongoing priority. This chapter describes the use of an insect cell expression system
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e57683e99bb454879d0583a5ed43af20
https://pubmed.ncbi.nlm.nih.gov/27076136
https://pubmed.ncbi.nlm.nih.gov/27076136
Autor:
Nikolai Petrovsky, Clifton McPherson, Manon M.J. Cox, Richard Chubet, Kathy Holtz, Yoshikazu Honda-Okubo, Dale L. Barnard
Publikováno v:
Vaccine Design ISBN: 9781493933853
Given periodic outbreaks of fatal human infections caused by coronaviruses, development of an optimal coronavirus vaccine platform capable of rapid production is an ongoing priority. This chapter describes the use of an insect cell expression system
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8014a6812ee283095aef487a4b8cd538
https://doi.org/10.1007/978-1-4939-3387-7_14
https://doi.org/10.1007/978-1-4939-3387-7_14
Publikováno v:
Vaccine
Numerous human infections with avian influenza viruses in Asia in recent years have raised the concern that the next influenza pandemic is imminent. The most effective way to combat influenza is through the vaccination of the public. However, a minim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfce323ef53b5221108fd8f171b23890
https://doi.org/10.1016/j.vaccine.2005.11.005
https://doi.org/10.1016/j.vaccine.2005.11.005
Autor:
Karen Anthony, Stacey Fader, Michel Ledizet, Joseph A. Rininger, Harald G. Foellmer, Paul Kaplan, Nathalie Bonafé, Raymond A. Koski, Sandra L. Bushmich, Richard Chubet, Erol Fikrig, John F. Anderson
Publikováno v:
Vaccine. 27(2)
In this study, a recombinant truncated West Nile virus envelope protein antigen (rWNV-E) was produced in serum-free cultures of the expresSF+ insect cell line via baculovirus infection. This production system was selected based on its use in the prod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6424d1a38494c5fe86cedaaf866f9046
https://pubmed.ncbi.nlm.nih.gov/18996430
https://pubmed.ncbi.nlm.nih.gov/18996430